Skip to main content

Advertisement

SpringerLink
Log in

Cardiopulmonary co-morbidity: a critical negative prognostic predictor for pulmonary resection following preoperative chemotherapy and/or radiation therapy in lung cancer patients

  • ORIGINAL ARTICLE
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective

Preoperative therapy is an optional strategy for locally advanced lung cancer, although the indication for pulmonary resection is often marginal, when considering the survival benefit and perioperative risks. The aim of the present study was to identify prognostic predictors by assessing clinical factors including prethoracotomy co-morbidity.

Methods

This was a retrospective analysis of 54 patients who underwent complete resection after preoperative therapy was performed.

Results

The overall 5-year survival rate was 38%. In patients without cardiopulmonary co-morbidity the 5-year survival rate was 49%, whereas it was 0% for those who had associated cardiopulmonary co-morbidity (P = 0.004). When analyzing only those who died from lung cancer, the group without cardiopulmonary co-morbidity showed a tendency for longer survival than those in the co-morbidity group (P = 0.092). The 5-year survival rate for patients—evaluated with a Charlson Co-morbidity Index (CCI)—with a CCI score of 0, was 45%, which tended to be better than that for those with a CCI score of 1–2 (P = 0.066). Furthermore, patients with a normal prethoracotomy level of carcinoembryonic antigen (CEA) had a 5-year survival rate of 44%, which was better than the 22% for patients with elevated CEA (P = 0.013). The 5-year survival rate for patients without lymph node metastasis was 52%, whereas it was 14% for those with residual node involvement (P = 0.002). Lymph node metastasis and cardiopulmonary co-morbidity were shown to be independent poor prognostic predictors by multivariate analysis.

Conclusion

In addition to nodal status, preoperative cardiopulmonary co-morbidity should be noted when considering the operative indications following preoperative therapy for lung cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. AL Visbal NB Leighl R Feld FA Shepherd (2005) ArticleTitleAdjuvant chemotherapy for early-stage non-small cell lung cancer Chest 128 2933–43 Occurrence Handle16236970 Occurrence Handle10.1378/chest.128.4.2933 Occurrence Handle1:CAS:528:DC%2BD2MXhtF2msL3O

    Article  PubMed  CAS  Google Scholar 

  2. KM Pisters T Le Chevalier (2005) ArticleTitleAdjuvant chemotherapy in completely resected non-small-cell lung cancer J Clin Oncol 23 3270–8 Occurrence Handle15886314 Occurrence Handle10.1200/JCO.2005.11.478 Occurrence Handle1:CAS:528:DC%2BD2MXltVWisL8%3D

    Article  PubMed  CAS  Google Scholar 

  3. JA Roth F Fossella R Komaki MB Ryan JB Putnam SuffixJr JS Lee et al. (1994) ArticleTitleA randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 673–80 Occurrence Handle8158698 Occurrence Handle10.1093/jnci/86.9.673 Occurrence Handle1:STN:280:ByuB3M%2FlsVM%3D

    Article  PubMed  CAS  Google Scholar 

  4. R Rosell J Gomez-Codina C Camps J Maestre J Padille A Canto et al. (1994) ArticleTitleA randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 153–8 Occurrence Handle8043059 Occurrence Handle10.1056/NEJM199401203300301 Occurrence Handle1:STN:280:ByuD1cfmvVY%3D

    Article  PubMed  CAS  Google Scholar 

  5. A Depierre B Milleron D Moro-Sibilot S Chevret E Quoix B Lebeau et al. (2002) ArticleTitleFrench Thoracic Cooperative Group: preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 247–53 Occurrence Handle11773176 Occurrence Handle10.1200/JCO.20.1.247

    Article  PubMed  Google Scholar 

  6. K Nagai R Tsuchiya T Mori H Tada Y Ichinose T Koike et al. (2003) ArticleTitleLung Cancer Surgical Study Group of the Japan Clinical Oncology Group: a randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J Thorac Cardiovasc Surg 125 254–60 Occurrence Handle12579093 Occurrence Handle10.1067/mtc.2003.15

    Article  PubMed  Google Scholar 

  7. M Machtay JH Lee JP Stevenson JB Shrager KM Algazy J Treat et al. (2004) ArticleTitleTwo commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response J Thorac Cardiovasc Surg 127 108–13 Occurrence Handle14752420 Occurrence Handle10.1016/j.jtcvs.2003.07.027 Occurrence Handle1:CAS:528:DC%2BD2cXhvVCjsro%3D

    Article  PubMed  CAS  Google Scholar 

  8. A Granetzny E Striehn U Bosse W Wagner O Koch U Vogt et al. (2003) ArticleTitleA phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer Ann Thorac Surg 75 1107–12 Occurrence Handle12683546 Occurrence Handle10.1016/S0003-4975(02)04719-7

    Article  PubMed  Google Scholar 

  9. KV Mattson RP Abratt G ten Velde K Krofta (2003) ArticleTitleDocetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study Ann Oncol 14 116–22 Occurrence Handle12488303 Occurrence Handle10.1093/annonc/mdg009 Occurrence Handle1:STN:280:DC%2BD38jisFeqsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. L Trodella P Granone S Valente S Margaritora G Macis A Cesario et al. (2004) ArticleTitleNeoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging Ann Oncol 15 389–98 Occurrence Handle14998840 Occurrence Handle10.1093/annonc/mdh099 Occurrence Handle1:STN:280:DC%2BD2c7gvVeltw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  11. E Pezzetta R Stupp A Zouhair L Guillou P Taffe C von Briel et al. (2005) ArticleTitleComparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC Eur J Cardiothorac Surg 27 1092–8 Occurrence Handle15896624 Occurrence Handle10.1016/j.ejcts.2005.02.035

    Article  PubMed  Google Scholar 

  12. E Perrot B Guibert P Mulsant S Blandin I Arnaud P Roy et al. (2005) ArticleTitlePreoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection Ann Thorac Surg 80 423–7 Occurrence Handle16039177 Occurrence Handle10.1016/j.athoracsur.2005.02.043

    Article  PubMed  Google Scholar 

  13. G Stamatis D Djuric W Eberhardt C Pottken G Zaboura S Fechner et al. (2002) ArticleTitlePostoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients Eur J Cardiothorac Surg 22 292–7 Occurrence Handle12142202 Occurrence Handle10.1016/S1010-7940(02)00266-X

    Article  PubMed  Google Scholar 

  14. JL Port RJ Korst PC Lee MA Levin DE Becker R Keresztes et al. (2005) ArticleTitleSurgical resection for residual N2 disease after induction chemotherapy Ann Thorac Surg 79 1686–90 Occurrence Handle15854955 Occurrence Handle10.1016/j.athoracsur.2004.10.057

    Article  PubMed  Google Scholar 

  15. N Sawabata SM Keller A Matsumura O Kawashima T Hirono Y Osaka et al. (2003) ArticleTitleJapan National Chest Hospital Study Group for Lung Cancer: the impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer Lung Cancer 42 69–77 Occurrence Handle14512190 Occurrence Handle10.1016/S0169-5002(03)00245-9

    Article  PubMed  Google Scholar 

  16. DC Betticher SF Hsu Schmitz M Totsch E Hansen C Joss C von Briel et al. (2003) ArticleTitleMediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 1752–9 Occurrence Handle12721251 Occurrence Handle10.1200/JCO.2003.11.040 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWqtrw%3D

    Article  PubMed  CAS  Google Scholar 

  17. ME Charlson P Pompei KL Ales CR MacKenzie (1987) ArticleTitleA new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373–83 Occurrence Handle3558716 Occurrence Handle10.1016/0021-9681(87)90171-8 Occurrence Handle1:STN:280:BiiC28nlsVc%3D

    Article  PubMed  CAS  Google Scholar 

  18. N Sawabata M Ohta S Takeda H Hirano Y Okumura H Asada et al. (2002) ArticleTitleSerum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer Ann Thorac Surg 74 174–9 Occurrence Handle12118753 Occurrence Handle10.1016/S0003-4975(02)03662-7

    Article  PubMed  Google Scholar 

  19. M Okada W Nishio T Sakamoto K Uchino T Yuki A Nakagawa et al. (2004) ArticleTitlePrognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease Ann Thorac Surg 78 216–21 Occurrence Handle15223432 Occurrence Handle10.1016/j.athoracsur.2004.02.009

    Article  PubMed  Google Scholar 

  20. O Birim AP Kappetein AJ Bogers (2005) ArticleTitleCharlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer Eur J Cardiothorac Surg 28 759–62 Occurrence Handle16157485 Occurrence Handle10.1016/j.ejcts.2005.06.046

    Article  PubMed  Google Scholar 

  21. D Moro-Sibilot A Aubert S Diab S Lantuejoul P Fourneret E Brambilla et al. (2005) ArticleTitleComorbidities and Charlson score in resected stage I nonsmall cell lung cancer Eur Respir J 26 480–6 Occurrence Handle16135732 Occurrence Handle10.1183/09031936.05.00146004 Occurrence Handle1:STN:280:DC%2BD2MvmslKnug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  22. TP Graeter D Hellwig K Hoffmann D Ukena CM Kirsch HJ Schafers (2003) ArticleTitleMediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy Ann Thorac Surg 75 231–5 Occurrence Handle12537221 Occurrence Handle10.1016/S0003-4975(02)04350-3

    Article  PubMed  Google Scholar 

  23. D Hellwig TP Graeter D Ukena T Georg CM Kirsch HJ Schafers (2004) ArticleTitleValue of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma J Thorac Cardiovasc Surg 128 892–9 Occurrence Handle15573074 Occurrence Handle10.1016/j.jtcvs.2004.07.031

    Article  PubMed  Google Scholar 

  24. C Doddoli F Barlesi D Trousse S Robitail S Yena P Astoul et al. (2005) ArticleTitleOne hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits J Thorac Cardiovasc Surg 130 416–25 Occurrence Handle16077407 Occurrence Handle10.1016/j.jtcvs.2004.11.022

    Article  PubMed  Google Scholar 

  25. M Ohta N Sawabata H Maeda H Matsuda (2003) ArticleTitleEfficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer J Thorac Cardiovasc Surg 125 96–100 Occurrence Handle12538990 Occurrence Handle10.1067/mtc.2003.91

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Thoracic and Cardiovascular Surgery, Osaka University Graduate School of Medicine, El-2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan

    Masayoshi Inoue MD, PhD, Meinoshin Okumura MD, PhD, Masato Minami MD, PhD, Hiroyuki Shiono MD, PhD, Noriyoshi Sawabata MD, PhD, Tomoki Utsumi MD, PhD & Yoshiki Sawa MD, PhD

  2. Department of Mathematical Health Science, Osaka University Medical School, Osaka, Japan

    Yuko Ohno PhD

Authors
  1. Masayoshi Inoue MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meinoshin Okumura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masato Minami MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Shiono MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noriyoshi Sawabata MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tomoki Utsumi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuko Ohno PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshiki Sawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masayoshi Inoue MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inoue, M., Okumura, M., Minami, M. et al. Cardiopulmonary co-morbidity: a critical negative prognostic predictor for pulmonary resection following preoperative chemotherapy and/or radiation therapy in lung cancer patients. Gen Thorac Cardiovasc Surg 55, 315–321 (2007). https://doi.org/10.1007/s11748-007-0140-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-007-0140-8

Key words

Search

Navigation